Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 248

1.

Biopsy-proven case of Epstein-Barr virus (EBV)-associated vasculitis of the central nervous system.

鹿野耕平 KK, Katayama T, Takeguchi S, Asanome A, Takahashi K, Saito T, Sawada J, Saito M, Anei R, Kamada K, Miyokawa N, Nishihara H, Hasebe N.

Neuropathology. 2016 Dec 22. doi: 10.1111/neup.12356. [Epub ahead of print]

PMID:
28004435
2.

Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group..

Hypertens Res. 2016 Dec 1. doi: 10.1038/hr.2016.158. [Epub ahead of print]

PMID:
27904156
5.

OS 27-02 CEREBRAL MICROBLEEDS AND ASYMPTOMATIC CEREBRAL INFARCTIONS IN PATIENTS WITH ATRIAL FIBRILLATION.

Saito T, Kawamura Y, Sato N, Hasebe N.

J Hypertens. 2016 Sep;34 Suppl 1 - ISH 2016 Abstract Book:e249.

PMID:
27754138
6.

OS 19-05 COMBINATION OF ARB AND NIFEDIPINE CR REDUCES MICROALBUMINURIA IN ASSOCIATION WITH REDUCTION OF SERUM URIC ACID: SUB-ANALYSIS OF NICE-COMBI STUDY.

Nakagawa N, Maruyama K, Matsuki M, Sato N, Kikuchi K, Hasebe N.

J Hypertens. 2016 Sep;34 Suppl 1 - ISH 2016 Abstract Book:e229.

PMID:
27754082
7.

Adult Accessory Mitral Valve with Septal Hypertrophy.

Aonuma T, Takehara N, Saito E, Hasebe N.

Intern Med. 2016;55(17):2515. doi: 10.2169/internalmedicine.55.6865. No abstract available.

8.

[Calcium channel blocker].

Takeuchi T, Hasebe N.

Nihon Rinsho. 2016 Jun 20;74 Suppl 4 Pt 1:562-7. Japanese. No abstract available.

PMID:
27534232
9.

Apoptosis-Resistant Cardiac Progenitor Cells Modified With Apurinic/Apyrimidinic Endonuclease/Redox Factor 1 Gene Overexpression Regulate Cardiac Repair After Myocardial Infarction.

Aonuma T, Takehara N, Maruyama K, Kabara M, Matsuki M, Yamauchi A, Kawabe J, Hasebe N.

Stem Cells Transl Med. 2016 Aug;5(8):1067-78. doi: 10.5966/sctm.2015-0281.

PMID:
27334489
10.

NLRP3 Deficiency Reduces Macrophage Interleukin-10 Production and Enhances the Susceptibility to Doxorubicin-induced Cardiotoxicity.

Kobayashi M, Usui F, Karasawa T, Kawashima A, Kimura H, Mizushina Y, Shirasuna K, Mizukami H, Kasahara T, Hasebe N, Takahashi M.

Sci Rep. 2016 May 26;6:26489. doi: 10.1038/srep26489.

11.

Left atrial enlargement and blood pressure variability in untreated hypertensive patients.

Nakagawa N, Hasebe N.

Hypertens Res. 2016 Aug;39(8):581-2. doi: 10.1038/hr.2016.55. No abstract available.

PMID:
27194574
12.

The results of a survey of physicians about the Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 and its clinical use.

Mogi M, Hasebe N, Horiuchi M, Shimamoto K, Umemura S.

Hypertens Res. 2016 Sep;39(9):660-3. doi: 10.1038/hr.2016.42.

PMID:
27169398
13.

Malnutrition, renal dysfunction and left ventricular hypertrophy synergistically increase the long-term incidence of cardiovascular events.

Maruyama K, Nakagawa N, Saito E, Matsuki M, Takehara N, Akasaka K, Sato N, Hasebe N.

Hypertens Res. 2016 Sep;39(9):633-9. doi: 10.1038/hr.2016.47.

PMID:
27169395
14.

Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.

Kawasaki A, Hasebe N, Hidaka M, Hirano F, Sada KE, Kobayashi S, Yamada H, Furukawa H, Yamagata K, Sumida T, Miyasaka N, Tohma S, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.

PLoS One. 2016 May 11;11(5):e0154393. doi: 10.1371/journal.pone.0154393.

15.

Insight into specific pro-arrhythmic triggers in Brugada and early repolarization syndromes: results of long-term follow-up.

Talib AK, Sato N, Myojo T, Sugiyama E, Nakagawa N, Sakamoto N, Tanabe Y, Fujino T, Takeuchi T, Akasaka K, Matsuhashi H, Saijo Y, Kawamura Y, Doi A, Hasebe N.

Heart Vessels. 2016 Dec;31(12):2035-2044.

PMID:
26968993
16.

Conifer-Derived Monoterpenes and Forest Walking.

Sumitomo K, Akutsu H, Fukuyama S, Minoshima A, Kukita S, Yamamura Y, Sato Y, Hayasaka T, Osanai S, Funakoshi H, Hasebe N, Nakamura M.

Mass Spectrom (Tokyo). 2015;4(1):A0042. doi: 10.5702/massspectrometry.A0042.

17.

eGFR and Outcomes in Patients with Acute Decompensated Heart Failure with or without Elevated BUN.

Kajimoto K, Sato N, Takano T; ATTEND investigators..

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):405-12. doi: 10.2215/CJN.08210815.

PMID:
26769764
18.

Sudden death prediction by C-reactive protein, electrocardiographic findings, and myocardial fatty acid uptake in haemodialysis patients: analysis of a multicentre prospective cohort sub-study.

Nakata T, Hashimoto A, Moroi M, Tamaki N, Nishimura T, Hasebe N, Kikuchi K, Nakatani E.

Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1394-1404.

PMID:
26710818
19.

A Sporadic Case of Fabry Disease Involving Repeated Fever, Psychiatric Symptoms, Headache, and Ischemic Stroke in an Adult Japanese Woman.

Sawada J, Katayama T, Kano K, Asanome A, Takahashi K, Saito T, Chinda J, Nakagawa N, Sato N, Kimura T, Yahara O, Momosaki K, Nakamura K, Hasebe N.

Intern Med. 2015;54(23):3069-74. doi: 10.2169/internalmedicine.54.4719.

20.

Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events COPE Trial Group..

Hypertens Res. 2016 Jan;39(1):46-53. doi: 10.1038/hr.2015.104.

Items per page

Supplemental Content

Loading ...
Support Center